Centene will exit the Medicare Advantage market in at least six states in 2025, according to an August 5 research brief by Stephens. This is a recent development, according to Stephens, an independent financial services firm and privately owned investment bank headquartered in Little Rock, Arkansas. Stephens maintains a market in the common stock of Centene.